Atrial Substrate Modification With Aggressive Blood Pressure Lowering to Prevent AF
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
Atrial fibrillation (AF) is a very common arrhythmia causing many symptoms resulting in
numerous hospitalizations. Catheter ablation is a technique that has evolved significantly to
improve symptomatic recurrences, but does not offer a 100% cure rate. We hypothesize that the
use of aggressive BP lowering will reduce the rate of recurrent AF after catheter ablation
for AF. We plan a randomized clinical trial of aggressive BP lowering versus standard BP
control to investigate this.